Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -51,128 | N/A | N/A |
| Depreciation Amortization | 693 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,211 | N/A | N/A |
| Other Working Capital | 1,197 | N/A | N/A |
| Other Operating Activity | 1,692 | 0 | 0 |
| Operating Cash Flow | $-46,335 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -964 | N/A | N/A |
| Investing Cash Flow | $-964 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 691 | N/A | N/A |
| Other Financing Activity | 23,278 | 0 | 0 |
| Financing Cash Flow | $23,969 | $N/A | $N/A |
| Beginning Cash Position | 40,585 | N/A | N/A |
| End Cash Position | 17,255 | N/A | N/A |
| Net Cash Flow | $-23,330 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -46,335 | N/A | N/A |
| Capital Expenditure | -968 | N/A | N/A |
| Free Cash Flow | -47,303 | 0 | 0 |